z-logo
Premium
Differential involvement of ERK 1‐2 and p38 MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F 2α
Author(s) -
Dekanty Andrés,
Giulianelli Sebastián,
Coso Omar A.,
Rudland Philip S.,
Jimenez de Asua Luis
Publication year - 2006
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2006.03.075
Subject(s) - cyclin d1 , mapk/erk pathway , kinase , signal transduction , microbiology and biotechnology , 3t3 cells , cell cycle , phosphorylation , retinoblastoma protein , prostaglandin f2alpha , transfection , chemistry , cyclin d , cyclin dependent kinase , biology , prostaglandin , gene , biochemistry
Prostaglandin F 2α (PGF 2α ) induces cyclin D 1 expression and DNA synthesis in Swiss 3T3 cells. In order to assess which signaling mechanisms are implicated in these processes, we have used both a pharmacological approach and interfering mutants. We demonstrate that PGF 2α induces extracellular‐signal‐regulated kinase (ERK 1‐2 ) and p38 MAPK activation, and inhibition of any of these signaling pathways completely blocks PGF 2α ‐stimulated DNA synthesis. We also show that ERK 1‐2 , but not p38 MAPK activation is required to induce cyclin D 1 expression, strongly suggesting that the concerted action of cyclin D 1 gene expression and other events are required to induce complete phosphorylation of retinoblastoma protein and S‐phase entry in response to PGF 2α .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom